A compilation of those areas of IPD which are usually not covered in classrooms. A greater emphasis on the management aspect with examples from existing hospitals in INDIA
A compilation of those areas of IPD which are usually not covered in classrooms. A greater emphasis on the management aspect with examples from existing hospitals in INDIA
The presentation describes in brief the patients need, expectations and how to develop the patient care and feedback system to obtain maximum patient satisfaction.
Hospital Committees are regular standing committees prescribed by regulatory agencies and deemed necessary by hospital administration in formulating policies, coordinating and monitoring hospital-wide activities that are considered critical in the delivery of quality health care services.
These are in contrast to ad hoc committees, department and unit committees.
NABH 5th edition hospital std april 2020anjalatchi
A. National Accreditation Board for Hospitals & Healthcare Providers (NABH) is a constituent board of Quality Council of India (QCI), set up to establish and operate accreditation programme for healthcare organizations.
The presentation describes in brief the patients need, expectations and how to develop the patient care and feedback system to obtain maximum patient satisfaction.
Hospital Committees are regular standing committees prescribed by regulatory agencies and deemed necessary by hospital administration in formulating policies, coordinating and monitoring hospital-wide activities that are considered critical in the delivery of quality health care services.
These are in contrast to ad hoc committees, department and unit committees.
NABH 5th edition hospital std april 2020anjalatchi
A. National Accreditation Board for Hospitals & Healthcare Providers (NABH) is a constituent board of Quality Council of India (QCI), set up to establish and operate accreditation programme for healthcare organizations.
McKesson helps improve health care quality and patient safety while reducing health care costs.
Task Actions
Task Not Started ( 00:00:00 )
*
*
*
*
*
*
*
*
Automatic replenishment ward stock on demand requestvxVistA.org
– Process on Setting Up the AR/WS Module
– Process on Submitting an On-Demand Request
– Documenting Administration of Floor
Stock/Clinic Stock Medication
Pharmacy as a profession and as a health care discipline has gone through phenomenal changes and development during the last few decades, at global as well as regional levels.
brief review on clinical pharmacy, drug information centre & patient safety program
The lecture was presented at Al-Mahmoudiya General Hospital as part of the training course for fresh appointed pharmacist at 16/5/2023 at 11 & 15/5/2023
This presentation is prepared to enhance the adherence of patient to their specific medication as prescribed by the physician and the role of pharmacist in improving the adherence of patient to their medication including various factors influence the adherence ,methods to measure adherence and methods to improve adherence .
Patient-Centric Approaches in Precision Medicine Trials: Strategies for SuccessClinosolIndia
Precision medicine, with its focus on tailoring medical treatment to the individual characteristics of each patient, has ushered in a new era in healthcare. Within this paradigm, clinical trials play a pivotal role in testing and validating targeted therapies. This article explores the importance of adopting patient-centric approaches in precision medicine trials and outlines strategies to enhance their success. By prioritizing patient engagement, leveraging digital technologies, and fostering collaborative partnerships, precision medicine trials can not only advance scientific understanding but also ensure that patient perspectives and experiences are integral to the research process.
Pharmacist Interventions and Medication Reviews at Care Homes - Improving Med...Health Innovation Wessex
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Pharmacist Interventions and Medication Reviews at Care Homes - Improving Medication Safety and Patient Outcomes, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
hOME MEDICATION REVIEW IS out standing self-employment opportunities with good clinical skills and hand on practice for pharm d students..its well an established program in Australia.
The framework for pharmacist prescribing in BC is focused on preventing patient harm by reducing preventable drug-related problems and providing safer transitions in care through increased involvement of pharmacists, as medication experts in the delivery of patient-centred collaborative care. Improving medication management and reducing preventable drug-related hospitalizations protects public safety and will improve patient outcomes.
Reduced risk factors for chronic disease, improved blood glucose, improved blood pressure, improved lipid levels, and reduced risk for major cardiovascular events are all examples of pharmacist prescribing in collaborative relationships preventing harm and improving patient outcomes in recent studies.
Earlier input from patients, pharmacists and other prescribers has been used to develop this new framework for pharmacist prescribing within collaborative practice.
Pharmacist prescribing is proposed to take place through interdisciplinary team-based care where physicians and nurse practitioners would continue to be responsible for the diagnosis, and access to health records and diagnostics, including lab tests, would be facilitated. Certified Pharmacist Prescribers would also be restricted from dispensing medications they prescribed for a patient. The framework also focuses closely on the benefit to patient care and identifies specific opportunities to prevent patient harm and improve patient outcomes.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
2. Patient-centred care is an innovative
approach to the planning, delivery, and
evaluation of health care that is grounded in
mutually beneficial partnerships among
health care providers, patients, and families.
Patient- and family-centered care applies to
patients of all ages, and it may be practiced
in any health care setting.’
3. core elements in these frameworks as:
• education and shared knowledge
• involvement of family and friends
collaboration and team management
• sensitivity to nonmedical and spiritual
dimensions of care
• respect for patient needs and preferences
• the free flow and accessibility of information.
4. Inpatient care is the care of patients whose
condition requires admission to a hospital.
Progress in modern medicine and the advent of
comprehensive out-patient clinics ensure that
patients are only admitted to a hospital when
they are extremely ill or are have severe physical
trauma.
Patients enter inpatient care mainly from
previous ambulatory care such as referral from a
family doctor, or through emergency medicine
departments. The patient formally becomes an
"inpatient" at the writing of an admission note.
5. The Inpatient Care Department allows to finish course of
therapy in an intimate and caring environment.
inpatient unit offers evaluation and treatment for a variety of
medical conditions. Supported by in-house diagnostic
imaging, pharmacy, physical therapy services, and 24-hour
clinician supervision
the Inpatient Care Department provides Health members with
timely and responsive care for a variety of medical issues.
services include:
Admission for continued care of patients transferred from the
hospital after surgery or serious illness, allowing for
smoother transition from hospital to home
Admission directly from any Yale Health clinical department
or from the Acute Care Department for further evaluation,
diagnosis or treatment for a range of common medical
problems
Procedures which require skilled medical services but not an
overnight stay
6. services include:
Admission for continued care of patients
transferred from the hospital after surgery or
serious illness, allowing for smoother
transition from hospital to home
Admission directly from any Health clinical
department or from the Acute Care
Department for further evaluation, diagnosis or
treatment for a range of common medical
problems
Procedures which require skilled medical
services but not an overnight stay
Physical therapy for inpatients
Hospice and palliative care
7. The well-being of the patient is the pharmacist’s primary
focus.Pharmacists offer their professional competence and skills to
support patients with the safe and rational use of medicines.
Pharmacists provide evidence based care. Pharmacists work
collaboratively with other health care professionals to advance best
practice and optimize treatment outcomes. Pharmacists contribute
to health promotion and disease prevention including lifestyle
counselling and supporting selfcare. Pharmacists guarantee and
demonstrate quality in their services,using valid indicators.Following
are different areas within the Hospital where pharmacist care work
for better patient care
Patient Safety
Drug Distribution and Dispensing
Clinical Program Development
Communication with Patients, Prescribers and Pharmacists
Drug Benefit Design
Cost Management
8. Drug Utilization Review (DUR)
programs:
This process can identify potential
prescription-related problems such as
drug/drug interactions, duplication of
drugs, known allergies, under- or
overdosing or inappropriate therapy.
Fraud and Abuse programs: Programs
that review key drug classes,
monitoring for patterns of
inappropriate use.
9. Prior Authorization (PA or “Prior Auth”) programs:
An approval process that encourages proper use of medications
and discourages inappropriate prescribing of medications.
Monitoring programs:
Some medications require lab-based monitoring or genomic
testing (i.e. personalized medicine) for product selection or
dosing Monitoring programs ensure that medications are
prescribed safely and used appropriately. Programs also involve
monitoring patient regimens for drug interactions and
medication adherence. Monitoring programs ensure that
medications are prescribed safely, used appropriately, and that
patients receive the best possible outcome.
Quality Assurance (QA) programs:
Standard of care programs that enhance patient safety, improve
the ways in which patients use medicaitons and ensure delivery
of high quality service.
10. Clinical Program Development
In order to enhance patient care, particularly for
patients with chronic conditions whose quality of life
depends on prescription drugs, managed care
pharmacists design clinical programs that:
Evaluate scientific evidence in order to select
appropriate medications for a patient population, A
thorough evaluation of the scientific and clinical data
regarding new medications must be made by a panel of
clinical experts within managed care organizations.
Called pharmacy and therapeutic (P&T) committees,
these panels generally include pharmacists, physicians
and other medical professionals.
Assess the effectiveness of new treatments for
diseases compared to standards of care.
11. Use evidence-based clinical and research data to create disease
manage- ment and medication therapy management programs
that help patients live more successfully with their medical
conditions and manage their drug therapies. Pharmacists
support physicians in the management of chronic and complex
diseases by monitoring regimens, assisting with cost saving
strategies, and counseling patients to improve adherence and
help minimize wastes and reduce costs.
Increase understanding of the way in which clinical therapies
affect quality of life, and implement programs that help ensure
such quality is achieved.
Explore ways of managing patients with chronic conditions who
are dependent on comprehensive drug therapies.
12. Communications with Patients, Prescribers and
Pharmacists
Managed care pharmacists design and use communication
protocols, such as those used within a call center or
medication therapy management program, to ensure that
there is an exchange of necessary information between
patients, their physicians and their pharmacists.
Communications are required to:
Notify physicians and other prescribers of drug safety
alerts and clinical updates to assist them in their
evaluation of patients’ therapies.
Help physicians and other prescribers choose medications
that will meet patients’ needs and be eligible for coverage.
13. Design and conduct outcomes-based
research in order to help patients achieve the
desired results from their drug therapy, and
enhance their ability to make quality-of-life
decisions.
Encourage appropriate prescribing and
proper use of medications through utilization
management (UM) programs such as prior
authorization (PA or Prior Auth) and quantity
limit (QL) programs
14. Provide patients with information on their
individual prescription history through
personalized reports.
Educate patients on their disease state and on
the medications they are taking or those being
suggested by their physicians. Provide the point
of care pharmacist with a more complete patient
profile and guidance on coverage issues to aid
them in their delivery of patient care.
Help patients manage their health care and help
physicians address complex medication therapy
questions.
15. Managed care pharmacists collaborate with other health care
professionals to design effective benefit structures that will
service a specific population’s needs. The pharmacist uses
clinical knowledge and practical experience to address such
design matters as:
How to structure a formulary (the approved list of
medications that a plan will cover) to encourage appropriate
and cost-effective therapy. Must decide whether the
formulary should be “restricted” or “open.” The level of
patient cost-sharing for generic, preferred brand-name
medications, and non-formulary medications must also be
established.
Whether a “participating” pharmacy network should be
established and, if so, how expansive should the network of
community, mail order and online pharmacies be to service
the population properly; what criteria for quality assurance
should participating pharmacies be expected to meet.
16. Establishment of criteria and procedures for drug
utilization
A criteria should be established to help safeguard that
patient safety and best outcomes are maximized, and that
patients receive the correct drug at the correct dosage,
understand why they are being asked to take the drug and
are compliant in taking the drug.
Establishment of a specific plan design for specialty
medications (i.e. high-cost medications that may require
special handling, administration or monitoring and are
used to treat chronic, complex disease states). Plan
designs may include limiting distribution, establishing
specific patient cost-shares and implementing utilization
management requirements
17. Managed care pharmacists contract with employer and
health plan clients,pharmacies and manufacturers to
structure business arrangements that:
Allow their clients to customize clinical and reporting
requirements to meet their individual population needs.
Negotiate with manufacturers for discounts on drug prices
for clients in exchange for moving market share when
clinically appropriate.
Assist clients in assessing the appropriateness of new
medications compared to existing therapeutic options.
Establish networks of pharmacies to provide accessibility
for patient popula- tions and assure participating
pharmacy compliance with patient safety and quality
programs and audit requirements.
18. Encouraging prescribers to make cost effective
drug choices that are clinically appropriate.
Integrating improvements so that costs are
actually saved, not merely shifted.
Introducing system interventions that enhance
the quality of patient care and save costs.
Using data to identify adherence and
nonadherence with prescribing guide- lines, and,
by creating measures for assessing physician
performance, identifying prescribing patterns
and determining opportunities for improvement.
Ensuring a scientific evaluation of cost for new
medications by applying pharmacoeconomics.
19. Encouraging prescribers to make cost effective
drug choices that are clinically appropriate.
Integrating improvements so that costs are
actually saved, not merely shifted.
Introducing system interventions that enhance
the quality of patient care and save costs.
Using data to identify adherence and
nonadherence with prescribing guidelines, and,
by creating measures for assessing physician
performance, identifying
prescribing patterns and determining
opportunities for improvement.
20. Ensuring a scientific evaluation of cost for
new medications by applying
pharmacoeconomics.
Managed care pharmacists contract with
employer and health plan clients,pharmacies
and manufacturers to structure business
arrangements Business Management
Managed care pharmacists help their clients
(employers, HMOs, trust funds,
Medicaid, etc.) evaluate and improve their
pharmacy benefit by:Cost Management
21. Methods for obtaining compensation or
economic and professional credit for value-added
services must continue to be addressed.
Structures designed to measure the practitioner’s
effectiveness as part of an innovative team
should be instituted. The pharmacy profession
should embrace these activities in the form of
well-structured research.Integrated health
systems will need to receive adequate support to
expand the availability of pharmacists to provide
pharmaceutical care as an essential component
of primary care